DI CARLO, EMMA
 Distribuzione geografica
Continente #
NA - Nord America 5.239
EU - Europa 3.955
AS - Asia 3.812
SA - Sud America 572
AF - Africa 48
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 4
Totale 13.635
Nazione #
US - Stati Uniti d'America 5.159
SG - Singapore 1.405
CN - Cina 1.300
UA - Ucraina 775
IE - Irlanda 630
TR - Turchia 564
GB - Regno Unito 539
IT - Italia 480
BR - Brasile 477
SE - Svezia 457
FR - Francia 399
DE - Germania 266
IN - India 176
VN - Vietnam 163
FI - Finlandia 161
RU - Federazione Russa 126
HK - Hong Kong 39
AR - Argentina 37
CA - Canada 35
MX - Messico 35
PL - Polonia 31
BD - Bangladesh 26
KR - Corea 23
IQ - Iraq 22
ZA - Sudafrica 21
EC - Ecuador 20
ES - Italia 20
JP - Giappone 17
BE - Belgio 14
NL - Olanda 14
PK - Pakistan 13
AT - Austria 12
UZ - Uzbekistan 10
CL - Cile 9
ID - Indonesia 9
IL - Israele 9
PY - Paraguay 9
VE - Venezuela 8
EG - Egitto 7
KE - Kenya 7
MA - Marocco 7
CZ - Repubblica Ceca 6
AE - Emirati Arabi Uniti 5
CO - Colombia 5
LT - Lituania 5
RO - Romania 5
EU - Europa 4
HU - Ungheria 4
AU - Australia 3
GR - Grecia 3
IR - Iran 3
JO - Giordania 3
KZ - Kazakistan 3
NP - Nepal 3
PE - Perù 3
SA - Arabia Saudita 3
TH - Thailandia 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
BH - Bahrain 2
BN - Brunei Darussalam 2
BY - Bielorussia 2
CH - Svizzera 2
JM - Giamaica 2
UY - Uruguay 2
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BO - Bolivia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GD - Grenada 1
GE - Georgia 1
GT - Guatemala 1
LB - Libano 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PH - Filippine 1
PT - Portogallo 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
TG - Togo 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 13.635
Città #
Singapore 990
Jacksonville 841
Chandler 702
Dublin 626
Southend 387
Dearborn 382
Princeton 310
Beijing 303
Dallas 281
Izmir 264
Nanjing 251
Ashburn 203
Wilmington 173
Cambridge 140
Los Angeles 136
The Dalles 129
Tongling 118
New York 105
Altamura 98
Santa Clara 83
Nanchang 78
Buffalo 75
Ann Arbor 73
Boardman 69
Chieti 61
Woodbridge 54
Ho Chi Minh City 50
Shenyang 47
Pescara 44
Hefei 43
São Paulo 43
Council Bluffs 39
Hebei 39
Hong Kong 39
Romola 37
Kunming 36
Grevenbroich 34
Dong Ket 32
Jiaxing 30
Redondo Beach 30
Houston 28
Chennai 27
Warsaw 27
Tianjin 26
Hanoi 24
Seoul 21
Hangzhou 20
Jinan 19
Norwalk 18
Brooklyn 17
Denver 17
Düsseldorf 17
Boston 16
Helsinki 16
Johannesburg 16
Orange 16
Changsha 15
Guangzhou 15
Tokyo 15
San Francisco 14
Chicago 13
Mexico City 13
Toronto 13
Atlanta 12
Lanciano 12
Phoenix 12
Poplar 12
Brussels 11
Falls Church 11
Munich 11
Nuremberg 11
Auburn Hills 10
Augusta 10
Frankfurt am Main 10
Orem 10
Rio de Janeiro 10
Belo Horizonte 9
Leawood 9
London 9
Manchester 9
Milan 9
Seattle 9
Stockholm 9
Tashkent 9
Washington 9
Baghdad 8
Caxias do Sul 8
Changchun 8
Curitiba 8
Lanzhou 8
Ningbo 8
San Mateo 8
Montreal 7
Porto Alegre 7
Zhengzhou 7
Amsterdam 6
Ankara 6
Bari 6
Camerino 6
Guayaquil 6
Totale 8.228
Nome #
Interleukin-30/IL-27p28 shapes prostate cancer stem-like cell behavior and is critical for tumor onset and metastasization 140
The prostate-associated lymphoid tissue (PALT) is linked to the expression of homing chemokines CXCL13 and CCL21. 135
Crucial pathophysiological role of CXCR2 in experimental ulcerative colitis in mice. 131
EDAP a member of TNF ligand superfamily is able to induce macrophage-granulocyte cross-talk. 128
The expression of LEC/CCL16, a powerful inflammatory chemokine, is upregulated in ulcerative colitis. 128
A "stealth effect": adenocarcinoma cells engineered to express TRAIL elude tumor-specific and allogeneic T cell reactions. 127
Analysis of mammary carcinoma onset and progression in HER-2/neu oncogene transgenic mice reveals a lobular origin. 126
Interleukin 6 gene transfected mouse mammary adenocarcinoma cells displaying an "in vitro" increased cell growth show an "in vivo" low tumor progression and a high metastatic potential. 125
CD25+ Regulatory T Cell Depletion Augments Immunotherapy of Micrometastases by an IL-21-Secreting Cellular Vaccine. 122
Ability of systemic interleukin-12 to hamper progressive stages of mammary carcinogenesis in HER2/neu transgenic mice. 122
In vivo studies of cytokines and growth factors involved in inflammation by using engineered tumor cells as biological minipumps. 118
Salivary carcinoma in HER-2/neu transgenic male mice: an angiogenic switch is not required for tumor onset and progression 116
Upregulation of TMEM16A protein in bronchial epithelial cells by bacterial pyocyanin 116
Inhibition of prostate carcinogenesis by combined active immunoprophylaxis 115
Interleukin-27 inhibits pediatric B-acute lymphoblastic leukemia cell spreading in a preclinical model. 115
Cure of mammary carcinomas in Her-2 transgenic mice through sequential stimulation of innate (neoadjuvant interleukin-12) and adaptive (DNA vaccine electroporation) immunity. 114
Absence of IL-12Rβ2 in CD33(+)CD38(+) pediatric acute myeloid leukemia cells favours progression in NOD/SCID/IL2RγC-deficient mice. 114
Androgen Deprivation Boosts Prostatic Infiltration of Cytotoxic and Regulatory T Lymphocytes and Has No Effect on Disease-Free Survival in Prostate Cancer Patients. 113
CD56(bright)perforin(low) noncytotoxic human NK cells are abundant in both healthy and neoplastic solid tissues and recirculate to secondary lymphoid organs via afferent lymph 113
Expression of IL-32 in human lung cancer is related to the histotype and metastatic phenotype and predicts clinical outcome 112
SNAI2/Slug gene is silenced in prostate cancer and regulates neuroendocrine differentiation, metastasis-suppressor and pluripotency gene expression 112
Endomyocardial infiltration by B and NK cells foreshadows the recurrence of cardiac allograft rejection 111
Complementary IL-23 and IL-27 anti-tumor activities cause strong inhibition of human follicular and diffuse large B-cell lymphoma growth in vivo. 111
Combined allogeneic tumor cell vaccination and systemic interleukin 12 prevents mammary carcinogenesis in HER-2/neu transgenic mice. 110
Interaction Between Endothelial Cells and the Secreted Cytokine Drives the Fate of An IL4- or An IL 5-Transduced Tumour 108
Coexpression of IL-6 and soluble IL-6R causes nodular regenerative hyperplasia and adenomas of the liver 108
IL-12 can target human lung adenocarcinoma cells and normal bronchial epithelial cells surrounding tumor lesions. 108
IL-12 mediated prevention of spontaneous tumors in C-neu transgenic inbred BALB/c and FVB mice. 107
Interleukin-27 re-educates intratumoral myeloid cells and down-regulates stemness genes in non-small cell lung cancer 106
Targeting tumor-related immunosuppression for cancer immunotherapy. 105
Electroporated DNA Vaccine Clears Away Multifocal Mammary Carcinomas in Her-2/neu Transgenic Mice 105
Constitutive expression of IL-12RB2 on human multiple myeloma cells delineates a novel therapeutic target. 104
Proinflammatory cytokines IL1 and IL6 are autocrine and/or paracrine growth factors for normal and neoplastic epithelial cells from human uterine cervix. 104
A light, nontoxic interleukin 12 protocol inhibits HER-2/neu mammary carcinogenesis in BALB/c transgenic mice with established hyperplasia. 103
Interleukin-30 Promotes Breast Cancer Growth and Progression 103
SPARC/Osteonectin production by tumor infiltrating macrophages promotes breast cancer metastatization. 102
Quilty effect has the features of lymphoid neogenesis and shares CXCL13-CXCR5 pathway with recurrent acute cardiac rejections 102
Local release of IL-10 by transfected mouse adenocarcinoma cells exhibits pro- and anti- inflammatory activity resulting in a delayed tumour rejection. 101
Interleukin 12-mediated Prevention of Spontaneous Mammary Adenocarcinomas in Two Lines of Her-2/neu Transgenic Mice 101
Targeting of IL-12 to human non small cell lung cancer counters tumor growth in vivo 101
Tumor cells engineered with IL-12 and IL-15 genes induce protective antibody responses in nude mice. 101
Neutrophils in anti-cancer immunological strategies: old players in new games 100
Timely DNA vaccine combined with systemic IL-12 prevents parotid carcinomas before a dominant-negative p53 makes their growth independent of HER-2/neu expression. 100
Immunological mechanisms elicited at the tumour site by lymphocyte activation gene-3 (LAG-3) versus IL-12: sharing a common Th1 anti-tumour immune pathway 100
Bevacizumab-mediated tumor vasculature remodelling improves tumor infiltration and antitumor efficacy of GD2-CAR T cells in a human neuroblastoma preclinical model 100
Immune Events Associated with the Cure Established Tumors and Spontaneous Metastases by Local and Systemic Interlukin 12 99
Down regulation of major histocompatibility complex class I expression in mammary carcinoma of Her-2/neu trangenic mice 99
The Immune Response Elicited by Mammary Adenocarcinoma Cells Transduced with Interferon-y and Cytosine Deaminase Genes Cures Lung Metastases by Parental Cells 99
Interleukin-23 acts as antitumor agent on childhood B-acute lymphoblastic leukemia cells. 99
OX40 ligand-transduced tumor cell vaccine synergizes with GM-CSF and requires CD40-Apc signaling to boost the host T cell antitumor response. 98
The lack of epithelial interleukin-7 and BAFF/BLyS gene expression in prostate cancer as a possible mechanism of tumor escape from immunosurveillance. 98
Expression of IL-32 in human lung cancer is related to the histotype and metastatic phenotype. 98
Immunopathological alterations of the prostate-associated lymphoid tissue (PALT) by androgen ablation in patients with prostate cancer 97
p185neu protein is required for tumor and anchorage-independent growth, not for cell proliferation of transgenic mammary carcinoma 96
Interleukin-30 expression in prostate cancer and its draining lymph nodes correlates with advanced grade and stage 96
LAG-3 enables DNA vaccination to persistently prevent mammary carcinogenesis in HER-2/neu transgenic BALB/c mice. 96
Interferon (IFN)-beta Gene Transfer into TS/A Adenocarcinoma Cells and Comparison with IFN-alpha. Differential Effects on Tumorigenicity and Host Response 95
The role of B lymphocytes and NK cells in cardiac allograft rejection. 95
Inactivation of interleukin-30 in colon cancer stem cells via CRISPR/Cas9 genome editing inhibits their oncogenicity and improves host survival 94
SOX2 boosts major tumor progression genes in prostate cancer and is a functional biomarker of lymph node metastasis 94
Dendritic cell recognition by ILC3 via DNAM-1 triggers pro-inflammatory reciprocal cell activations 94
Tumor rejection and immune memory elicited by locally released LEC chemokine are associated with an impressive recruitment of APCs, lymphocytes, and granulocytes. 93
Inhibition of mammary carcinogenesis by systemic interleukin 12 or p185neu DNA vaccination in Her-2/neu transgenic BALB/c mice. 93
The Quilty Effect: an actor in search of a part 93
Induced somatic inactivation of STAT3 in mice triggers the development of a fulminant form of enterocolitis. 92
Immunoprevention of HER-2/neu transgenic mammary carcinoma through an interleukin 12-engineered allogeneic cell vaccine. 92
Development of rhabdomyosarcoma in HER-2/neu transgenic p53 mutant mice. 92
The prostate-associated lymphoid tissue (PALT) is heavily compromised in prostate cancer but differently altered depending on androgen ablation. 92
The prostate-associated lymphoid tissue (PALT) is driven by CXCL13 and CCL21 expression. 92
Clinical impact of the lung tissue transcriptome in a teenager with multifocal invasive mucinous adenocarcinoma-a case report 92
Direct inhibition of human acute myeloid leukemia cell growth by IL-12. 91
The antitumor potential of Interleukin-27 in prostate cancer 91
Dissimilar anti-tumour reactions induced by tumour cells engineered with the interleukin-2 or interleukin-15 gene in nude mice 90
Signaling through 3',5'-Cyclic Adenosine Monophosphate and Phosphoinositide-3 Kinase Induces Sodium/Iodide Symporter Expression in Breast Cancer. 90
Insertion of the DNA for the 163-171 peptide of IL1beta enables a DNA vaccine encoding p185(neu) to inhibit mammary carcinogenesis in Her-2/neu transgenic BALB/c mice. 90
The IL-12Rbeta2 gene functions as a tumor suppressor in human B cell malignancies. 90
Lack of Il12rb2 signaling predisposes to spontaneous autoimmunity and malignancy. 90
Interleukin-27 Acts as Multifunctional Anti-Tumor Agent in Multiple Myeloma. 90
Mammary carcinoma provides highly tumourigenic and invasive reactive stromal cells. 90
Interleukin 6 gene-transfected mouse mammary adenocarcinoma: tumour cell growth and metastatic potential. 89
The combined action of IL-15 and IL-12 gene transfer can induce tumor cell rejection without T and NK cell involvement. 89
Prevention of spontaneous neu-expressing mammary tumor development in mice transgenic for rat proto-neu by DNA vaccination. 89
Immunoprevention of mammary carcinoma in HER-2/neu transgenic mice is IFN-gamma and B cell dependent. 89
Colorectal Cancer-Associated Immune Exhaustion Involves T and B Lymphocytes and Conventional NK Cells and Correlates With a Shorter Overall Survival 89
Methylation of the IL-12Rbeta2 gene as novel tumor escape mechanism for pediatric B-acute lymphoblastic leukemia cells. 88
Immunological prevention of a multigene cancer syndrome. 88
CX3CL1/Fractalkine expression by antigen presenting cells and endothelial cells leads to NK cell recruitment in human cardiac allograft rejection. 87
The enigmatic role of interleukin-12 in the pathogenesis of Sjögren's syndrome: comment on the article by Vosters et al. 87
Gene transfer of a modified human IL-15 cDNA in lung cancer cells: analyses of biological effects. 87
Inhibition of mammary carcinoma development in HER-2/neu transgenic mice through induction of autoimmunity by xenogeneic DNA vaccination. 86
Prevention by delay: nonspecific immunity elicited by IL-12 hinders Her-2/neu mammary carcinogenesis in transgenic mice. 86
Network of immunoregolatory cell subsets and mediators involved in human cardiac allograft rejection. 85
EphA3 targeting reduces in vitro adhesion and invasion and in vivo growth and angiogenesis of multiple myeloma cells 85
Nonredundant roles of antibody, cytokines, and perforin in the eradication of established Her-2/neu carcinomas. 84
Therapy of lung metastases through combined vaccination with carcinoma cells engineered to release IL-13 and IFN-gamma. 84
Immunization in tumor prevention. 84
IL-18 cDNA vaccination protects mice from spontaneous lupus-like autoimmune disease. 84
The intriguing role of polymorphonuclear neutrophils in antitumor reactions. 83
Endogenous IL-12 triggers an antiangiogenic program in melanoma cells. 83
Neutrophils in the antitumoral immune response 83
Totale 10.042
Categoria #
all - tutte 56.678
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.678


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021485 0 0 0 0 0 224 14 6 38 126 19 58
2021/2022585 29 9 8 91 52 16 11 52 40 25 71 181
2022/20232.099 175 212 114 254 222 442 114 142 290 51 54 29
2023/2024791 77 34 48 20 36 246 231 15 1 12 8 63
2024/20252.435 157 318 316 95 44 62 38 152 296 134 300 523
2025/20262.530 459 305 553 640 397 176 0 0 0 0 0 0
Totale 14.190